A49.3
Mycoplasma infection, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Mycoplasma infections are caused by bacteria from the Mycoplasma genus, which are unique bacteria lacking a cell wall. These infections can affect various parts of the body, leading to a range of health issues. The ICD-10 code A49.3 is used to classify cases where the specific site of the Mycoplasma infection is not identified or specified. While Mycoplasma bacteria most commonly cause respiratory illnesses, they can also be involved in other infections, making recognition and diagnosis essential for appropriate management.
Causes & Symptoms
Clinical Causes: Transmission through respiratory droplets when an infected person coughs or sneezes. Close contact with infected individuals, especially within households or communal settings. Less common routes include contact with contaminated surfaces or objects. Potential for asymptomatic carriage, where individuals carry the bacteria without showing symptoms. In some cases, underlying health conditions may predispose individuals to infection.
Key Symptoms: Persistent dry cough, which may be severe or lingering. Fever and chills, often mild but sometimes more prominent. Sore throat and difficulty swallowing. Fatigue and general malaise. Shortness of breath or chest discomfort in some cases. Infections at other sites may cause localized symptoms depending on the affected area, such as urinary symptoms or skin issues.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory testing, including:
Treatment Protocols: Treatment generally involves antibiotics effective against Mycoplasma bacteria, such as:
Clinical Advice & FAQs
Billing Guidance
Is A49.3 a billable ICD-10 code?
Yes, A49.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A49.3?
Clinical documentation must specify the nature of Mycoplasma infection, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
